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Killer toxin secretion was blocked at the restrictive temperature in Saccharo-
myces cerevisiae sec mutants with conditional defects in the S. cerevisiae
secretory pathway leading to accumulation of endoplasmic reticulum (sec18),
Golgi (sec7), or secretory vesicles (secl). A 43,000-molecular-weight (43K)
glycosylated protoxin was found by pulse-labeling in all sec mutants at the
restrictive temperature. In secl8 the protoxin was stable after a chase; but in sec7
and seci the protoxin was unstable, and in secl 11K toxin was detected in cell
lysates. The chymotrypsin inhibitor tosyl-L-phenylalanyl chloromethyl ketone
(TPCK) blocked toxin secretion in vivo in wild-type cells by inhibiting protoxin
cleavage. The unstable protoxin in wild-type and in sec7 and secl cells at the
restrictive temperature was stabilized by TPCK, suggesting that the protoxin
cleavage was post-secl8 and was mediated by a TPCK-inhibitable protease.
Protoxin glycosylation was inhibited by tunicamycin, and a 36K protoxin was
detected in inhibited cells. This 36K protoxin was processed, but toxin secretion
was reduced 10-fold. We examined two kex mutants defective in toxin secretion;
both synthesized a 43K protoxin, which was stable in kexi but unstable in kex2.
Protoxin stability in kexi kex2 double mutants indicated the order kexi -* kex2 in
the protoxin processing pathway. TPCK did not block protoxin instability in kex2
mutants. This suggested that the KEXI- and KEX2-dependent steps preceded the
sec7 Golgi block. We attempted to localize the protoxin in S. cerevisiae cells. Use
of an in vitro rabbit reticulocyte-dog pancreas microsomal membrane system
indicated that protoxin synthesized in vitro could be inserted into and glycosylat-
ed by the microsomal membranes. This membrane-associated protoxin was
protected from trypsin proteolysis. Pulse-chased cells or spheroplasts, with or
without TPCK, failed to secrete protoxin. The protoxin may not be secreted into
the lumen of the endoplasmic reticulum, but may remain membrane associated
and may require endoproteolytic cleavage for toxin secretion.
Type 1 killer Saccharomyces cerevisiae cells
contain Ml double-stranded RNA (dsRNA), a
cytoplasmic plasmid encapsulated in virus-like
particles. The virus-like plasmid contains genes
coding for a secreted 11,000-molecular-weight
(11K) protein toxin and an unidentified immuni-
ty protein determining resistance to this toxin,
which confer the killer (K,+), immune (R1+)
phenotype of killer strains (see references 3 and
18 for recent reviews).
The system allows a genetic approach to be
taken toward understanding protein secretion in
this simple eucaryote. The toxin resembles
many secreted proteins in that it is made as a
larger precursor. The primary translation prod-
uct in vitro is a 32 to 36K preprotoxin. This
precursor is processed cotranslationally in vitro
by dog pancreas microsomal membranes to a
43K glycoprotein, a protoxin with a 1.6K amino-
terminal signal sequence removed (1, 2). A 43K
glycoprotein protoxin is also found in vivo in
pulse-labeled killer cells (2, 4), and the protoxin
has a precursor-product relationship to the se-
creted toxin in a pulse-chase experiment. Ml
dsRNA killer plasmid mutants which are defec-
tive in protoxin processing and are unable to
secrete toxin have been described (4).
In this paper we examine processing and
secretion of toxin in mutants defective in nuclear
genes that control secretion, and we show toxin
secretion to be on a pathway defined by the
secretory sec mutants of Novick and Schekman
(11) and the kex mutants of Wickner and
Leibowitz (9, 19). In addition, we examine the
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SECRETION OF S. CEREVISIAE KILLER TOXIN 1363
effect of tunicamycin and protease inhibitors on
toxin processing and attempt to localize the
protoxin in producing cells.
MATERIALS AND METHODS
Yeast strains and media. The diploid S. cerevisiae
T158C/S14a (ATCC 46427) was used as a typical K1
killer strain (4). The secretory mutant strains HMSF1
seci-l, HMSF6 sec7-1, and HMSF176 secl8-1 were
obtained from R. Schekman. These temperature-sensi-
tive, nonkiller sec mutants were crossed with a killer
strain, A8207B [KIL-kl] a his4C-64; the killer diploid
sporulated, and the asci dissected. All spores were
killer (K+ R'), two per tetrad were temperature-
sensitive mutants, and one temperature-sensitive K+
R' mutant was taken from each cross for use. All four
spores from a secl-l cross gave a 43K protoxin when
cell lysates were immunoprecipitated with antitoxin
antiserum after pulse-labeling with [35S]sulfate for 20
min at 24°C.
The following kex mutant strains were used and all
were [KIL-kl]; a kex2-1 ura- ade-; a kexl-3 ade-; S90
a kex2 ade2 ural; S91 a kexl-l argi thri; 3413-1OB a
kexl-I kex2-1 ural thrl; 3413-8A a kexl-1 kex2-1 ade2
his7 argi thri. All but the first two strains were from
the laboratory of Reed Wickner.
Growth medium was the minimal medium described
previously (4) supplemented as appropriate with 0.5%
yeast extract-0.5% peptone-2% glucose. For some
pulse-labeling experiments, a sulfate-free minimal me-
dium (4) was used plus 0.25 mM homocysteine thiolac-
tone as a sulfur source (11).
dsRNA isolation and in vitro translation. M1 dsRNA
was isolated from killer strain T158C/S14a and dena-
tured and translated in a rabbit reticulocyte lysate
system as described previously (4). EDTA-stripped,
micrococcal nuclease-treated dog pancreas microsom-
al membranes, prepared by the Shields and Blobel (15)
procedure, were obtained from Gordon Shore. Tetra-
caine was obtained as Pontocaine from Winthrop
Laboratories; trypsin was obtained from Boehringer
Mannheim Corp.
Immunoprecipitation of toxin and toxin precursor.
Cultures were labeled with [35S]sulfate (carrier-free,
New England Nuclear Corp.) or [35S]methionine
(Amersham Corp.), and cells and medium were ob-
tained by centrifugation. Growth medium was concen-
trated with ultrafiltration cones (CF-25; Amicon
Corp.). Cells were lysed with glass beads, and the
lysates and medium concentrates were immunoreact-
ed with antitoxin antiserum and protein A-Sepharose
as described previously (4).
Immunoreactants were subjected to sodium dodecyl
sulfate (SDS)-polyacrylamide gel electrophoresis and
fluorography as described previously (4). To estimate
the intensity of protoxin and toxin bands, films were
scanned with a densitometer (Ortec), and the areas
under the peaks were estimated by weighing. To
correct for sample variability in gel lanes, protoxin
levels were normalized relative to a stable, nonspecific
protein migrating at approximately 48K on the gels. To
determine protoxin half-lives in mutants, decay curves
from at least two pulse-chase experiments were plot-
ted, and half-lives were estimated and averaged.
Protease inhibitors were tosyl-L-phenylalanyl chlor-
omethyl ketone (TPCK), N-carbobenzoxy-L-pheny-
lalanyl chloromethyl ketone, phenylmethylsulfonyl
fluoride, tosyl-L-lysyl chloromethyl ketone, tosyl-L-
arginyl-methylester, and chymostatin. They were ob-
tained from Sigma Chemical Co. Inhibitors insoluble
in water were dissolved in dimethyl sulfoxide before
use as described previously (5).
RESULTS
Killer toxin processing and secretion in sec
mutants. Novick and Schekman have isolated
and characterized a series of conditional-lethal
mutants defective in protein secretion and cell
surface growth (11). At the restrictive tempera-
ture, these mutants accumulate secretory organ-
elles and can be ordered into a pathway that is
remarkably similar to that seen in mammalian
cells (10).
We studied killer toxin processing and secre-
tion in three such mutants that accumulate endo-
plasmic reticulum (secl8), Golgi (sec7), or secre-
tory vesicles (secl) at the restrictive
temperature. To examine toxin processing and
secretion in sec mutants, we constructed sec
[KIL-kl] strains by standard genetic techniques.
The strains had normal K+ R+ killer phenotypes
at 24°C but failed to grow at 37°C.
The sec killer strains were grown at 24°C,
switched to 37°C for 1 to 1.5 h, pulse-labeled for
10 min, chased, and the label in toxin and
precursors examined (Fig. 1 and 2). No detect-
able toxin was secreted at 37°C in the secl strain
(Fig. 1A, lanes d, e, and f), although a wild-type
strain (T158C/S14a) secreted toxin under similar
growth and labeling conditions (Fig. 1A, lanes a,
b, and c). A similar blockage of toxin secretion
at 37°C was found in sec7 and secl8 strains (data
not shown). We examined toxin precursors that
had accumulated at the sec blocks by immuno-
reaction of cell lysates with antitoxin serum. In
all cases, a 43K protoxin was detected after a
pulse (see Fig. 1B, lane a for secl; Fig. 2, lanes b
and f for sec7 and secl8, respectively). The
protoxin was identical in size to that seen in
these mutants at 24°C and to the protoxin from a
wild-type strain (data not shown). Pulse-chase
experiments indicated that in secl8 the protoxin
was stable after a 60-min chase at 37°C (Fig. 2,
lanes g and h), whereas for sec7 the protoxin
was unstable with a half-life of approximately 45
min (Fig. 2, lanes c and d). In the secl strain, the
protoxin was more labile, with a half-life of
approximately 15 min (Fig. 1B, lanes b and c). In
secl, but not secl8 or sec7, cell lysates 11K
toxin was also found (see Fig. IB), although no
toxin or protoxin was secreted. Protoxin in a
wild-type strain at 37°C was less stable than in
the seci strain. Protoxin was not detectable after
a 30-min chase (data not shown), indicating a
half-life of less than 10 min. By 30 min at 37°C,
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FIG. 1. Synthesis of protoxin and secretion of kill-
er toxin in SEC] and secl killer strains of 37°C. Strains
were grown at 24°C, switched to 37°C for 1 h, labeled
with [35S]sulfate for 10 min, and chased with cold
sulfate for up to 1 h at 37°C. (A) Secreted proteins
were obtained from the growth medium, and after
concentration they were applied to an SDS-polyacryl-
amide gel, electrophoresed, and a fluorogram of the
gel obtained. Lanes a through c (in SECJ) chase
duration: lane a, 0 min; lane b, 30 min; lane c, 60 min.
Toxin is seen in lanes b and c as the band just below
the 13K marker. Lanes d through f (in secl) chase
duration: lane d, 0 min; lane e, 30 min; lane f, 60 min.
(B) Cells were lysed and proteins immunoreacted with
antitoxin antiserum. The immunoreactive species
were electrophoresed on an SDS-polyacrylamide gel,
and a fluorogram was made. Lanes a through c, secl;
lanes d through f, sec) treated with TPCK during
labeling. Chase duration: lanes a and d, 0 min; lanes b
and e, 30 min; lanes c and f, 60 min. The protoxin band
migrated at 43K.
secreted 11K toxin was clearly visible in the
growth medium (Fig. 1A, lane b).
Novick and Schekman (11) showed that acid
phosphatase and invertase, accumulated in the
secretory vesicles in a secl mutant at 37°C, were
secreted after lowering the culture temperature
from 37°C to the permissive temperature of 240C
and in the absence of further protein synthesis.
In a similar experiment, a seci killer strain was
grown at 370C and pulse-labeled with [35S]sul-
fate. After the pulse, protein synthesis was
inhibited with cycloheximide, the culture was
transferred to 24°C, and toxin synthesis was
examined (Fig. 3). Protoxin made at 370C de-
creased with time at 240C (Fig. 3A) and, in
contrast to the situation at 370C, this decrease in
protoxin coincided with an increase in the
amount of secreted l1K toxin (Fig. 3B). Note
also that several other secreted proteins made at
37°C were chased out at 240C under these condi-
tions.
Effect of tunicamycin on protoxin glycosylation
and toxin secretion. Glycosylation of protoxin
was previously identified in vitro by endoglyco-
sidase H susceptibility (2). To determine the
importance of glycosylation for toxin matura-
tion, we examined the effect of tunicamycin (7)
on in vivo protoxin synthesis and processing. A
culture of killer strain (T158C/S14a) was incu-
bated with tunicamycin, pulse-chased with
[35S]sulfate, and samples of cell lysate and
growth medium taken for analysis of protoxin
and secreted toxin. The results (Fig. 4) showed
that tunicamycin inhibited synthesis of the 43K
protoxin, whereas a 36K species, immunoreac-
tive with antitoxin serum, was detected in cell
lysates in the presence of the drug (Fig. 4A, lane
d). This 36K precursor, presumably devoid of
any N-asparaginyl-linked polysaccharide, was
similar in size to the preprotoxin synthesized in
68 K.. - _ > . >- . w ~~4 3 K
._6~ ~ ~ .3
<,n K'
3 K
FIG. 2. Processing of protoxin in secl8 and sec7
strains at 370C. Strains were grown at 24°C, shifted to
37°C for 1.5 h, labeled with [35S]sulfate for 10 min, and
chased with cold sulfate for 60 min at 37°C. Cells were
lysed, immunoreacted with antitoxin antiserum, elec-
trophoresed, and a fluorogram obtained. Lanes a
through d (in sec7) chase duration: lane a, 0 min,
preimmune serum; lane b, 0 min, antitoxin serum; lane
c, 30 min; lane d, 60 min. Lanes e through h (in secl8)
chase duration: lane e, 0 min, preimmune serum; lane
f, 0 min, antitoxin serum; lane g, 30 min; lane h, 60
min.
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.43 K
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of tunicamycin could result from instability of
the unglycosylated protoxin. However, in a
pulse-chase experiment, the kinetics of unglyco-
sylated protoxin decay were measured and
found to be identical to those of the glycosylated
A a b
pr F1-
c d e
-_68K
0me *
4*a
-
43K
- 30K
- 13K
_43K
30K
B
_13 K
FIG. 3. Protoxin decay and toxin secretion after a
switch of a seci strain pulse-labeled at 37 to 240C in the
presence of cycloheximide. The secl strain was grown
at 37°C for 1 h and pulse-labeled with [35S]sulfate for
10 min at 37°C. Cycloheximide (120 ,ug/ml) was added
with 1o-4 M sodium sulfate, and the culture was
transferred to 240C. (A) Cells were lysed, immunor-
eacted with antitoxin antiserum, and immunoreactants
electrophoresed and fluorographed. Lane a, 10-min
pulse at 37°C, antitoxin antiserum; lane b, 10-min
pulse at 370C, pre-immune serum; lane c, 30-min chase
at 240C, antitoxin antiserum; lane d, 30-min chase at
240C, pre-immune serum; lanes e through g, antitoxin
antiserum, 15-, 45-, and 60-min chase at 24°C, respec-
tively. (B) Medium was taken, concentrated, electro-
phoresed, and fluorographed. Lane a, 10-min pulse at
37°C; lanes b through e, 15-, 30-, 45-, and 60-min
chases, respectively, at 24°C with cycloheximide.
Toxin appears as a 11K band just below the 13K
marker.
vitro (Fig. 4A, lane c). Although no 43K pro-
toxin was detected in the presence of tunicamy-
cin, a small amount of 11K toxin was secreted
(Fig. 4B, lanes a and c) which was approximate-
ly 10% of that produced in the absence of
tunicamycin (Fig. 4B, lanes b and d). Immuno-
reaction of secreted proteins showed that the
11K toxin was the only secreted cross-reactive
component (Fig. 4B, lanes a and b).
Decreased secretion of toxin in the presence
a b c d
-68K
_43K
-30K
_ 13K
4
FIG. 4. Effect of tunicamycin on protoxin glycosy-
lation and toxin secretion in vivo. Killer strain
T158C/S14a was incubated at 30°C for 30 min with
tunicamycin at 15 pLg/ml. The culture was labeled with
[35S]sulfate for 10 min and, where indicated, chased
for a further 27 min with cold sulfate. (A) Cell lysates
were prepared and immunoreacted with antitoxin anti-
serum, electrophoresed, and a fluorogram obtained.
Lanes a and b, lysates of untreated control cells, 10-
min pulse, pre-immune and antitoxin antiserum, re-
spectively; lane c, in vitro translation of denatured M
dsRNA immunoreacted with antitoxin antiserum;
lanes d and e, tunicamycin-treated cell lysates, 10-min
pulse, immunoreacted with antitoxin and pre-immune
sera, respectively. (B) Growth medium concentrated,
immunoreacted with antitoxin serum, electrophor-
esed, and fluorographed. Lanes a and c, culture fluid
from pulse-chased tunicamycin-treated cells, immun-
oreacted and total secreted protein, respectively; lanes
b and d, culture fluid from pulse-chased untreated
control cells, antitoxin immunoreacted and total se-
creted protein, respectively.
A a b c d e f 9
B a b d e
gw
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FIG. 5. Effect ofTPCK on toxin secretion and protoxin stability. Killer strain T158C/S14a was grown at 30°C,
TPCK (1 mM) was added, followed 5 min later by a [35S]sulfate pulse for 10 min and a cold sulfate chase for 40
min. Fluorograms of culture medium and cell lysate proteins were obtained after immunoreaction and
electrophoresis. (A) Total medium proteins. Lane a, TPCK-inhibited medium proteins; lane b, control medium
proteins, no treatment. (B) Cell lysates immunoreacted with antitoxin antiserum. Lane a, pre-immune serum, 10-
min pulse; lane d, antitoxin antiserum, 10-min pulse; lane b, antitoxin antiserum, 10-min pulse, 40-min chase;
lane c, TPCK treated,- 10-min pulse, 40-min chase, antitoxin antiserum.
precursor (data not shown). In a further experi-
ment based on the procedure of Katz et al. (6),
the 43K protoxin was shown to be a glycopro-
tein, as it was retained by a concanavalin A-
Sepharose column, whereas the 36K prepro-
toxin was not (data not shown). Retention of the
43K protoxin was blocked by 0.2 M a-methyl-D-
mannoside, but not by 0.2 M D-galactose.
Protoxin cleavage is blocked by TPCK. To try
to prevent cleavage of toxin from the protoxin,
protease inhibitors were added to the growth
medium of a killer strain, and secreted toxin was
measured after a pulse with [35S]sulfate and a
chase of variable duration. The chymotrypsin
inhibitor, TPCK (14), prevented toxin secretion
(Fig. 5A, lane a) as did N-carbobenzoxy-L-
phenylalanyl chloromethyl ketone, although
toxin was secreted in the presence of phenyl-
methylsulfonyl fluoride, tosyl-L-arginyl-methyl-
ester, tosyl-L-lysyl chloromethyl ketone or chy-
mostatin (data not shown). Although TPCK
blocked toxin secretion, it did not prevent secre-
tion of many medium proteins (Fig. 5A, compare
lanes a and b). Examination of cell lysates from
pulse-labeled TPCK-treated cells, after a chase
period sufficient for labeled protoxin to have
disappeared from untreated cells, showed that
the protoxin persisted and remained cell-associ-
ated, which is consistent with TPCK blockage of
protoxin cleavage and nonsecretion of protoxin
(Fig. 5B, compare lanes b and c). Toxin-sized
material was also found in TPCK-inhibited cells.
This material may arise from degradation of
protoxin on extraction or may imply a more
complex mode of action of TPCK.
At the restrictive temperature, the secl mu-
tant had an unstable toxin precursor in a pulse-
chase experiment. The secl precursor was con-
siderably more stable in the presence of TPCK
(Fig. 1B, lanes d, e, and f), with approximately
77% of precursor still present after 60 min,
compared with approximately 8% remaining in
the uninhibited secl cells. The sec7 precursor
was also more stable in the presence of TPCK,
with no significant decay after 60 min, compared
with some 40% remaining in the uninhibited sec7
cells (results not shown).
Protoxin synthesis in kex mutants. The prod-
ucts of two nuclear genes, KEXI and KEX2,
appear essential for protoxin processing. Muta-
tions in these genes lead to loss of ability to
secrete toxin while retaining normal M dsRNA
plasmids (9, 12, 19). We examined kexi and kex2
mutants for toxin precursors in a pulse-chase
experiment. The result (Fig. 6, lanes a and c)
indicated that both mutants were able to make a
43K protoxin. In kexi, the protoxin was relative-
ly stable after a chase, with 42% remaining after
a 40-min chase. In kex2, the protoxin was unsta-
ble, with less than 10%o remaining after a 40-min
chase. In neither case was secreted toxin or
precursor detected, although in kexi a very
diffuse band of lower molecular weight than the
toxin was detectable by immunoreaction with
antitoxin antiserum.
To order these mutations in the protoxin proc-
essing pathway, we used two kexi kex2 double
mutants in an experiment similar to that seen in
Fig. 6. In both experiments, the same result was
obtained, the protoxin was stable after a chase,
with greater than 60%o remaining after 60 min
(data not shown) which suggested the order kexl
-+ kex2. In a further experiment, we tested
whether the unstable protoxin in kex2 mutants
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FIG. 6. Protoxin stability in killer expression mu-
tants kexi and kex2. Cultures were grown at 30°C,
pulse-labeled with [35S]methionine for 10 min, and
chased with unlabeled methionine (10'- M) for a
further 40 min. Cell lysates and growth medium were
immunoreacted with antitoxin antiserum, electrophor-
esed, and fluorographed. Lanes a, b, and e (in kexi)
lane a, 10-min pulse; lanes b and e, 40-min chase of cell
lysate and medium, respectively; lanes c, d and f (in
kex2) lane c, 10-min pulse; lanes d and f, 40-min chase
of cell lysate and medium, respectively.
could be stabilized with TPCK in a pulse-chase
experiment. The protoxin remained unstable in
two kex2 alleles under these conditions and
implied that the kex mutations act before the
TPCK-inhibitable step.
Localization of protoxin synthesized in vitro. A
series of experiments was aimed at determining
whether the protoxin is a secreted protein or an
integral membrane glycoprotein. In vitro trans-
lation of denatured M1 dsRNA in a reticulocyte
lysate in the presence of dog pancreas micro-
somal membranes gave a 36K preprotoxin and a
glycosylated 43K protoxin (2) (Fig. 7, lane a).
Appearance of the 43K protoxin was dependent
upon the cotranslational presence ofdog pancre-
as microsomal membranes; only the 36K species
was found if the membranes were added post-
translationally (Fig. 7, lane g). Treatment of the
precursors synthesized in vitro with trypsin
showed that the 43K protoxin was relatively
resistant to trypsin digestion, although the 36K
species was fully degraded (Fig. 7, lanes a, b,
and c). One interesting additional feature seen in
some trypsin digestion experiments was the ap-
pearance of a diffuse immunoreactive 1lK band
(see Fig. 7, lanes e and f). This band, with the
size and antigenic determinants of toxin, pre-
sumably results from cleavage of the protoxin at
approximately the normal processing site for
toxin production. The product, like toxin itself,
is relatively resistant to further trypsin proteoly-
sis. Protection of the protoxin synthesized in
vitro from trypsin proteolysis was dependent
upon the presence of tetracaine (Fig. 7, lanes c
and d), a substance known to stabilize micro-
somal membranes in this system (13). The addi-
tion of Triton X-100 to the system before addi-
tion of trypsin abolished the protection of the
protoxin (Fig. 7, lanes e and f). Apparent com-
plete protection of the protoxin from trypsin
degradation indicated that the protoxin either
could be an integral membrane protein or could
be released within the vesicle lumen with no
lysine- or arginine-containing region of the pro-
toxin exposed on the exterior.
Localization of protoxin in vivo. If the protoxin
were released within the lumen of secretory
vesicles in vivo, it might be secreted transiently
during normal toxin synthesis or stably under
conditions where toxin cleavage was inhibited.
No secreted precursor was found in pulse-la-
beled cells (4) or in the medium of TPCK-
inhibited cells where protoxin accumulated and
no toxin was secreted (Fig. 5A, lane a). Because
protoxin could be periplasmic and although se-
creted it was unable to traverse the cell wall, we
investigated precursor secretion in spheroplasts
a b c d e f 8
-68K
_43 K
_30K
_ 1 3K
FIG. 7. Stability of glycosylated protoxin to tryp-
sin digestion in an in vitro translation system with dog
pancreas microsomal vesicles. Denatured dsRNA was
translated in an in vitro system with dog pancreas
microsomal vesicles. Translation was stopped with
cycloheximide (110 pLgml), and tetracaine (3 mM) was
added and incubated for 5 min at room temperature.
Trypsin was added at the indicated concentration and
incubated for a further 10 min at room temperature.
Incubation was terminated by the addition of SDS
(0.25%) and soybean trypsin inhibitor (170 pug/ml).
Samples were immunoreacted with antitoxin antibody,
electrophoresed, and a fluorogram prepared. Lane a,
complete system, no trypsin; lane b, 20 ,ug of trypsin
per ml; lane c, 30 ILg of trypsin per ml; lane d, no
tetracaine, 30 F'g of trypsin per ml; lane e, 30 p.g of
trypsin per ml; lane f, Triton X-100 (1%) added post-
translationaily, plus 30 ,ug of trypsin per ml; lane g,
dog pancreas microsomal vesicles added posttransla-
tionally, no trypsin.
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1368 BUSSEY ET AL.
that were pulse-chased with [35SJmethionine.
The results (Fig. 8B) indicated that the ilK
toxin appeared as a secreted protein in sphero-
plasts, but the protoxin did not. The protoxin
remained associated with the spheroplast pellet
(Fig. 8A). In spheroplasts where protoxin cleav-
A a b K.eI
_GNW IM
Z t
.-
-- 480mamb -..-~~~~~~~~~.:
B a b e
FIG. 8. Location of protoxin and toxin
labeled spheroplasts. Spheroplasts of T
were labeled with [35S]methionine for 15
chased with cold methionine (10-3 M) for 44
spheroplasts were obtained by centrifuga
concentrated medium and lysed spheropl
immunoreacted with antitoxin antiserum, a
munoreactants were electrophoresed and a f
made. (A) Lysed spheroplasts. Lane a, 15-l
antitoxin antiserum; lane b, 15-min pulse, pi
serum; lanes c through e, 10-, 20-, and 30-i
respectively, antitoxin antiserum. (B) Sec
teins in growth medium. Lane a, 15-min
immune serum; lane b, 15-min pulse, antitox
um; lanes c through e, 10-, 20-, and 30-n
respectively, antitoxin antiserum.
age was inhibited by TPCK, an identical pulse-
chase experiment gave the same result; the
protoxin did not decay (compare Fig. SB) and
remained associated with the spheroplast pellet.
No protoxin was detectable in the spheroplast
medium (data not shown).
We attempted to demonstrate directly the cell
surface location of protoxin blocked in cleavage
by mutation or by TPCK and chased to the
membrane-associated site. Spheroplasts of
TPCK-inhibited cells or of mutant Ni that accu-
mulates a stable protoxin (4) were pulse-labeled
and chased, and the stability of the protoxin was
challenged with externally added pepsin. In nei-
ther case was protoxin degraded by the prote-
ase. Control experiments indicated that the pro-
toxin in spheroplasts was susceptible to pepsin
cleavage after solubilization with SDS.
DISCUSSION
The use of temperature-sensitive sec mutants
has defined a secretory pathway in S. cerevisiae
that is similar, in at least major respects, to that
3 K in mammals (10). Use of sec mutants containing
the killer plasmid clearly demonstrates that kill-
er toxin secretion occurs along this pathway. At
the restrictive temperature, toxin secretion is
blocked in mutants defective in transfer from the
endoplasmic reticulum, Golgi, or secretory vesi-
cles.
Glycosylation of the protoxin appears to be
complete by the endoplasmic reticulum stage, as
protoxin taken from secl8 at the restrictive
temperature is identical in size (as judged by
68 K electrophoretic mobility in SDS) to that in secl8
at the permissive temperature or in a wild-type
strain. This suggests that major extension of the
43K core glycosides added at this early stage does
not occur during subsequent events in secretion
30OK of toxin, which is in contrast to that which
occurs with invertase (10). This finding was
strengthened by results of in vitro processing by
1 3 K dog pancreas microsomal membranes capable of
effecting core glycosylation (2) (see above). The
in pulse- protoxin synthesized was again apparently iden-1l58CP/5s4ea tical in size to that seen in vivo. Much of the ini5min and vivo modification of the protoxin is by di-N-
) min. The acetylchitobiosyl N-glycosidic bonding to aspar-
Ltion. The agine residues, as it is sensitive to endoglycosi-
lasts were dase H and inhibited in vivo by tunicamycin,
nd the im- which blocks N-acetyl glucosamine addition to
luorogram dolichol phosphate (2). However, two observa-
min pulse, tions suggest that this does not account for all of
rei immune the protoxin modification seen in vivo. The
etedchase unglycosylated preprotoxin synthesized in vitro
,ulse pro- and still containing the amino-terminal signalpin antiser- sequence is similar in size to the precursor
nin chase, produced in vivo in the presence of tunicamycin
which presumably lacks this signal sequence. It
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is also similar in size to the product of endogly-
cosidase H treatment of the in vivo protoxin (2).
Perhaps a non-N-glycosidic-linked polysaccha-
ride or other component may be added to the
protoxin during secretion, accounting for the
size difference seen. The N-glycosidic-linked
polysaccharide moiety of the protoxin seems to
be necessary for efficient toxin secretion, as
severe (90%) inhibition of toxin secretion was
found in the presence of tunicamycin.
The sec mutants also define when proteolytic
cleavage of the toxin precursor occurs in the
secretory pathway. In sec18, the endoplasmic
reticulum-blocked mutant, the precursor was
stable after a 60-min chase at the restrictive
temperature. In sec7 and secl, which accumu-
late Golgi and secretory vesicles, respectively,
the precursor was unstable although more stable
in sec7 than in secl. In secl, ilK toxin was
detected in cell lysates at the restrictive tem-
perature. The precursor instability in sec7 and
secl can be prevented by the addition of TPCK
to the culture. This protease inhibitor was also
shown to prevent cleavage of protoxin in vivo in
a wild-type strain. These results strongly suggest
that protoxin cleavage by a TPCK-inhibitable
protease does not occur until after the secl8
block but can occur with low efficiency before
the sec7 Golgi step. The proteolytic processing
of proinsulin is thought to occur within the
secretion granules formed within the Golgi and
to continue as they move to the cytosol (16, 17).
This decrease in stability from sec7- to secl-
blocked mutants would fit this pattern, with only
partial activation of protease activity occurring
before the sec7 Golgi block. In principle, exami-
nation of other Golgi- and secretory vesicle-
blocked sec mutants for ability to cleave pro-
toxin may resolve more closely the stage of
onset of proteolytic cleavage in the pathway. M
dsRNA plasmid mutant Ni, which fails to se-
crete toxin (4), has a phenotype similar to that
seen in TPCK-inhibited cells; a stable nonsecret-
ed protoxin is found in pulse-labeled cells. The
Ni mutant protoxin may well be a poor sub-
strate for the TPCK-inhibitable endoprotease.
Mutants harboring kexi or kex2 lesions give
further information on the protoxin processing
pathway. The moderate stability of protoxin in
kexl mutants and marked instability in kex2
mutants permits an ordering of these gene prod-
ucts; kexl kex2 double mutants have a stable
protoxin, suggesting the order kexi -* kex2 in
the pathway. We can tentatively order the KEX-
dependent steps in the secretion pathway de-
fined by the sec mutants. The finding that TPCK
does not stabilize protoxin in kex2 mutants indi-
cates that instability in kex2 mutants involves a
TPCK-resistant system that fails to act on the
protoxin of wild-type or kexl cells and suggests
that TPCK acts after the kex2 step. The kexi and
kex2 steps occur after synthesis of the 43K
protoxin in the endoplasmic reticulum but be-
fore the sec7 Golgi block when the TPCK-
inhibitable protease is active. A more definitive
ordering of kex mutants awaits the results of
appropriate sec kex double mutant experiments.
The nature of the KEX-dependent steps is un-
known, but they are essential for toxin secre-
tion. The instability of protoxin in kex2 mutants
may result from susceptibility of the protoxin to
degradation by proteases not inhibitable by
TPCK. The processing pathway outlined above
implies that protoxin regains a TPCK-dependent
stability after the KEX2 step. This could come
about through change in the structure or confor-
mation of the protoxin or from its altered loca-
tion and exposure to proteases in the secretory
organelles. One possible defect would be that in
kex2 mutants, protoxin is rerouted to the vacu-
ole instead of to the Golgi, with subsequent
degradation by vacuolar proteases. Wild-type
cells with correct routing of the protoxin to
Golgi would retain a stable protoxin if the
TPCK-inhibitable processing protease were pre-
vented from acting.
Neither the kexi nor the kex2 mutation is
lethal, so these gene products are not essential
for all secreted proteins and may define a secre-
tory subpathway. Mutants in kex2 secrete an
altered set of proteins; some proteins such as
killer toxin and a-factor are missing (9, 12, 19),
whereas others are secreted as species that are
altered in isoelectric point and are of apparent
higher molecular weight, as if incompletely
processed. The a-factor sex pheromone is also
thought to be synthesized as a precursor (8), and
presumably both protoxin and pro-a-factor have
a common, essential KEX2-dependent step.
Two general pathways for toxin secretion are
possible. First, the protoxin is secreted into the
lumen of the endoplasmic reticulum, and this
secreted precursor is cleaved after the secl8
block into an amino-terminal toxin and a car-
boxy-terminal remnant which is also secreted or
degraded. Second, the protoxin is an integral
membrane protein with an amino-terminal por-
tion extending into the lumen of the endoplasmic
reticulum and with hydrophilic glycosylated and
hydrophobic membrane-inserted regions distal
to the toxin sequence. The precursor would be
cleaved with the cleavage step necessary for
toxin secretion. The remnant carboxy-terminal
glycoprotein would remain as an integral mem-
brane protein, probably located on the exterior
of the cytoplasmic membrane after vesicle fu-
sion with the membrane (2).
In vitro trypsin protection experiments with
microsomal membrane vesicles, although dem-
onstrating protection, did not resolve these pos-
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sibilities. Analysis of protoxin location in cyto-
plasmic mutants that accumulate protoxin (4) in
TPCK-inhibited killer cultures and in pulse-la-
beled cells and spheroplasts gave the same re-
sult; the protoxin did not behave as a conven-
tional secreted or periplasmic glycoprotein.
Protoxin always remained associated with the
cell or spheroplast pellet fraction. The precise
location of the protoxin is unknown, but irre-
spective of its exact location, cleavage of pro-
toxin appears necessary for toxin secretion.
Cleavage of proproteins destined for secretion to
generate mature, active proteins is of wide-
spread occurrence in eucaryotes (17). Such
processed proproteins are thought to be secreted
into the lumen of the endoplasmic reticulum. We
know of no other example resembling killer
protoxin maturation in which cleavage of an
apparently membrane-associated proprotein
generates a secreted protein.
The possible role of the remnant carboxy-
terminal, membrane-associated portion of the
protoxin remains unknown. It has been specu-
lated that it may be the immunity component (1,
2), and this remains an attractive possibility.
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